LAXAF — Laxai Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Laxai Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2005 December 31st	2006 December 31st	2007 December 31st	2008 December 31st	2009 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12.1	13.7	0	0	0
Cost of Revenue
Gross Profit	4.37	4.78	—	—	—
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	11.9	13.5	1.57	1.92	0.382
Operating Profit	0.11	0.156	-1.57	-1.92	-0.382
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.109	0.174	-1.63	-1.93	-0.404
Provision for Income Taxes
Net Income After Taxes	0.109	0.174	-1.63	-1.93	-0.404
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	0.276	0.21	-1.63	-1.93	-0.404
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	0.276	0.21	-1.63	-1.93	-0.404
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.036	0.027	-0.036	-0.043	-0.007
Dividends per Share